“Guardians of the Gulf” Selected to Premiere at LA Femme International Film Festival This Month
7.10.2020 16:00:00 EEST | Business Wire | Press release
Guardians of the Gulf , an eye-opening documentary that explores the tumultuous relationship between the Gulf of Mexico and the conservationists determined to protect it, has been selected to premiere at the all-digital LA Femme International Film Festival October 15 – 18. Mary Kay Inc., serving as executive producer, with Media One in partnership with The Nature Conservancy, visited the coasts of Texas, Alabama and Mexico to shed light on the often-untold stories of Gulf preservation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201007005109/en/
Guardians of the Gulf, produced by Mary Kay Inc., has been selected to premiere at the LA Femme International Film Festival. (Photo: Mary Kay Inc.)
Filmed, directed and produced by an all-female crew, Guardians of the Gulf is slated for its global digital premiere on Friday, October 16, 5:00 p.m. PST, with a Q&A including film makers and stars to immediately follow.
Guardians of the Gulf Synopsis:
The Gulf of Mexico has long been impacted by catastrophic natural disasters like hurricanes, overfishing, agricultural run-off and oil spills. However, it continues to support one of the most biodiverse ecosystems on Earth with over 15,000 species. This resilience is tenuous. Like any relationship—only so much can be taken without giving back.
In Guardians of the Gulf, the Gulf of Mexico is given a voice by her caretakers to tell a story of generosity and strength. These conservationists, fisherpeople, tour operators, chefs and student leaders strive to improve sustainability in their work and community. Through action, they see change. Through change, they see hope.
Learn more at https://www.guardiansofthegulf.com.
The LA Femme International Film Festival is a premiere film festival celebrating, supporting and advancing content creation by women producers, writers, and directors from around the world. The festival has advanced the careers of over 1,000 artists and continues to offer educational seminars, programming and networking events in a nurturing indie environment.
Film Credits:
Cait Martin Newnham - Director
Ulla Laidlaw - Director
Aine Corby - Producer
Jenny Williams - Producer
Gayle Ye – Director of Photography
Mary Kay - Executive Producer
Quotes:
“Water isn’t a single issue. It touches every facet of modern life and the only evidence we need for this is the Gulf of Mexico. Where some see its mounting interdependencies as a challenge too great, we see opportunity and a chance to bring more people along with us, as we innovate solutions and change the trajectory for the hardest-working body of water in the world. After watching Guardians of the Gulf, it’s our hope that viewers will have a newfound appreciation for not only the Gulf but the tireless and collaborative efforts being made to sustain it for generations to come.”
Laura Huffman, former Regional Director of The Nature Conservancy in Texas and featured in Guardians of the Gulf
“While learning about the Gulf of Mexico and its recent history, we found ourselves overwhelmed by the depth of its tragedies and their impact. But then we met the incredible people of the Gulf and we quickly acknowledged that a story of hopelessness didn’t fit. We wanted to reflect the strength and resilience of the Gulf in the film’s narrative to give the ecosystem a voice to inspire action and hope.”
Cait Martin Newnham, Director of Guardians of the Gulf
“While we were making Guardians of the Gulf, we fell in love with the Gulf of Mexico. She emerged quickly as a character who is generous, adaptable and powerful. The Gulf gives life and a route for migration to over 15,000 species, and provides humans with food, income and protection from natural disasters. Her reach is far, and her plight is symbolic of the global climate crisis.”
Ulla Laidlaw, Director of Guardians of the Gulf
“One of the most pervasive themes of this documentary is hope. Hope that we are not just maintaining the Gulf of Mexico but how action can result in tangible change. With hope, more people are motivated to take action, and the wave of sustainability continues to swell. The all-female team did an incredible job capturing the dynamism of the Gulf of Mexico. The documentary showcases the people fighting to protect the Gulf and the ability to make change happen. Our hope is Guardians of the Gulf inspires curious minds to learn how they can act locally to impact global sustainability.”
Julia Simon, Chief Legal, Communications and Social Impact Officer for Mary Kay Inc.
About Mary Kay
One of the original glass ceiling breakers, Mary Kay Ash founded her beauty company more than 56 years ago with three goals: develop rewarding opportunities for women, offer irresistible products, and make the world a better place. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skin care, color cosmetics, nutritional supplements and fragrances. Mary Kay is committed to empowering women and their families by partnering with organizations from around the world, focusing on supporting cancer research, protecting survivors from domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Mary Kay Ash’s original vision continues to shine—one lipstick at a time. Learn more at MaryKay.com.
About Media One Creative
Media One is a global creative and production studio specializing in commercial, documentary, and short form content for the brands we love. We pride ourselves on a fully integrated creative and production process which enables us to unite brands with target audiences through authentic storytelling.
Since 2012, we’ve been moving audiences to action with an in-house team of experts in creative development, audio and video production. Learn more at mediaonecreative.ca .
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201007005109/en/
Contact information
Mary Kay Inc. Corporate Communications
marykay.com/newsroom
972.687.5332 or media@mkcorp.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano ® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 14:00:00 EEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 14:00:00 EEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
Samsung Biologics Strike: Labor Union Warns of CDMO Supply Chain Risks Following Overwhelming Vote30.3.2026 12:52:00 EEST | Press release
The Samsung Biologics Labor Union (President: Jaesung Park), representing approximately 75% of the company's total employees, announced today that its members have overwhelmingly voted in favor of a strike, with 95.52% voting in favor on a 95.38% turnout during a voting period from March 24 to March 29. Following the Incheon Regional Labor Relations Commission's decision to cease mediation, the union has now secured the legal mandate to strike. The union stressed that this strike is not merely a wage dispute. It stems from deep structural concerns regarding the company’s ESG management, lack of operational autonomy, and passive labor relations. Primarily, the union highlighted unresolved corporate governance issues, including allegations concerning unfair labor practices and the unauthorized use of employee personal data, which were prominently reported by South Korea's major broadcaster, MBC, in November 2025. The union believes this crisis stems from management's failure to address r
The Premier Jumping League (PJL) Launches with a Record-Breaking $300 Million Guaranteed Prize Pot, Defining a New Era for Showjumping30.3.2026 12:00:00 EEST | Press release
The Premier Jumping League (PJL) launches with a record-breaking $300 million guaranteed prize pot, defining a new era for showjumping. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330990938/en/ Photography credits: Daniel Benson for The Premier Jumping League/ Wieden+Kennedy London Backed by McCourt Global and its Executive Chairman, Frank McCourt, the PJL is a groundbreaking global competition that elevates high-performance riders and horses to their rightful place on the world stage. Built on merit, integrity, and excellence, the PJL brings together the world’s best athletes to compete for the biggest prize pot in the discipline’s history, helping to create a more resilient, long-term financial model for the sport. Represented by sixteen teams, the PJL will introduce an industry-first rider selection process from a pool of 250 of the world’s leading riders. World-class, immersive events will unfold across fourteen ic
Dompé Announces First Patient Enrolled in New Study of Intranasal NGF in Cerebral Palsy30.3.2026 12:00:00 EEST | Press release
Dompé, a leading biopharmaceutical company with operations in Italy and in the U.S., announced that the first patient has been enrolled at the Agostino Gemelli IRCCS University Hospital in Rome, Italy, in a Phase 2 investigational study of an intranasal form of Nerve Growth Factor (NGF) (Cenegermin-bkbj) for the treatment of spastic cerebral palsy (CP). On top of safety and tolerability, the study will evaluate improvements in daily functioning, quality of life, motor abilities, and neurodevelopmental measures of the Cenegermin-bkbj intranasal formulation. CP is the most common motor disability in childhood, caused by injury or changes during early brain development. The most prevalent form, spastic CP, leads to muscle stiffness and difficulty with movement.2 “Cerebral palsy is a devastating disease, and for patients and families there are still no proven treatments beyond supportive care,” said Marcello Allegretti, Chief Scientific Officer at Dompé. “With our emerging intranasal NGF p
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
